{
  "retracted": false,
  "timestamp": 1102982400000,
  "updates": [
    {
      "timestamp": 1586368136316,
      "identifier": {
        "doi": "10.1073/pnas.0404694101"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1073/pnas.0402653101"
  },
  "publisher": "Proceedings of the National Academy of Sciences",
  "title": "Correction for Bielekova et al., Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon Â , PNAS 2004 101:8705-8708"
}
